Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lin

Showing results (871-880 of 912) with videos related to

Pageof 92
Sort By:
Bone Marrow Transplantation|March 15, 2016
Early relapse post autologous transplant is a stronger predictor of survival compared with pretreatment patient factors in the novel agent era: analysis of the Singapore Multiple Myeloma Working GroupS Y Ong, S de Mel, Y X Chen, et al.
Nature Communications|December 19, 2013
Phylogenetic applications of whole Y-chromosome sequences and the Near Eastern origin of Ashkenazi LevitesSiiri Rootsi, Doron M Behar, Mari Järve, et al.
The Journal of Bone and Joint Surgery. American Volume|January 7, 2021
Low Adherence to Recommended Guidelines for Open Fracture Antibiotic ProphylaxisCarol A Lin, Nathan N O'Hara, Sheila Sprague, et al.
JCO Clinical Cancer Informatics|May 1, 2026
Interpreting Treatment Effects Using Posterior Probabilities: A Bayesian Reanalysis of 230 Phase III Oncology TrialsAlexander D Sherry, Pavlos Msaouel, Gabrielle S Kupferman, et al.
European Journal of Human Genetics : EJHG|August 26, 2010
A major Y-chromosome haplogroup R1b Holocene era founder effect in Central and Western EuropeNatalie M Myres, Siiri Rootsi, Alice A Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2024
Proportional Hazards Violations in Phase III Cancer Clinical Trials: A Potential Source of Trial MisinterpretationTimothy A Lin, Zachary R McCaw, Alex Koong, et al.
JAMA Oncology|June 4, 2019
Factors Associated With Age Disparities Among Cancer Clinical Trial ParticipantsEthan B Ludmir, Walker Mainwaring, Timothy A Lin, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
β-hydroxybutyrate is a metabolic regulator of proteostasis in the aged and Alzheimer disease brainS S Madhavan, S Roa Diaz, S Peralta, et al.
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi|December 1, 2025
[Application of multidisciplinary team diagnosis and treatment model in the management of patients with combined burns and heat stroke]S S Jiang, N N Wang, H H Wang, et al.
European Journal of Human Genetics : EJHG|December 7, 2006
A counter-clockwise northern route of the Y-chromosome haplogroup N from Southeast Asia towards EuropeSiiri Rootsi, Lev A Zhivotovsky, Marian Baldovic, et al.
Pageof 92

Showing results (871-880 of 912) with videos related to

Sort By:
Pageof 92
Bone Marrow Transplantation|March 15, 2016
Early relapse post autologous transplant is a stronger predictor of survival compared with pretreatment patient factors in the novel agent era: analysis of the Singapore Multiple Myeloma Working GroupS Y Ong, S de Mel, Y X Chen, et al.
Nature Communications|December 19, 2013
Phylogenetic applications of whole Y-chromosome sequences and the Near Eastern origin of Ashkenazi LevitesSiiri Rootsi, Doron M Behar, Mari Järve, et al.
The Journal of Bone and Joint Surgery. American Volume|January 7, 2021
Low Adherence to Recommended Guidelines for Open Fracture Antibiotic ProphylaxisCarol A Lin, Nathan N O'Hara, Sheila Sprague, et al.
JCO Clinical Cancer Informatics|May 1, 2026
Interpreting Treatment Effects Using Posterior Probabilities: A Bayesian Reanalysis of 230 Phase III Oncology TrialsAlexander D Sherry, Pavlos Msaouel, Gabrielle S Kupferman, et al.
European Journal of Human Genetics : EJHG|August 26, 2010
A major Y-chromosome haplogroup R1b Holocene era founder effect in Central and Western EuropeNatalie M Myres, Siiri Rootsi, Alice A Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2024
Proportional Hazards Violations in Phase III Cancer Clinical Trials: A Potential Source of Trial MisinterpretationTimothy A Lin, Zachary R McCaw, Alex Koong, et al.
JAMA Oncology|June 4, 2019
Factors Associated With Age Disparities Among Cancer Clinical Trial ParticipantsEthan B Ludmir, Walker Mainwaring, Timothy A Lin, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
β-hydroxybutyrate is a metabolic regulator of proteostasis in the aged and Alzheimer disease brainS S Madhavan, S Roa Diaz, S Peralta, et al.
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi|December 1, 2025
[Application of multidisciplinary team diagnosis and treatment model in the management of patients with combined burns and heat stroke]S S Jiang, N N Wang, H H Wang, et al.
European Journal of Human Genetics : EJHG|December 7, 2006
A counter-clockwise northern route of the Y-chromosome haplogroup N from Southeast Asia towards EuropeSiiri Rootsi, Lev A Zhivotovsky, Marian Baldovic, et al.
Pageof 92